Related Articles
Canaccord Genuity Downgrades ZoomInfo to Hold From Buy, Adjusts Price Target to $5 From $12
ZoomInfo (GTM) has an average rating of hold and mean price target of $6.82, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Benchmark Initiates Tandem Diabetes Care at Hold
Tandem Diabetes Care (TNDM) has an average rating of overweight and mean price target of $31.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Piper Sandler Downgrades ZoomInfo to Underweight From Neutral, Adjusts Price Target to $4 From $7
ZoomInfo (GTM) has an average rating of hold and mean price target of $6.82, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)